An O-GlcNAcylomic Approach Reveals ACLY as a Potential Target in Sepsis in the Young Rat
Authors:
- Manon DenisMDManon Denis
- Thomas DupasTDThomas Dupas
- Antoine PerselloAPAntoine Persello
- Justine DontaineJDJustine Dontaine
- Laurent BultotLBLaurent Bultot
- Charlotte BetusCBCharlotte Betus
- Thomas PeléTPThomas Pelé
- Justine DhotJDJustine Dhot
- Angélique ErraudAEAngélique Erraud
- Anaïs MaillardAMAnaïs Maillard
- Jérôme MontnachJMJérôme Montnach
- Aurélia A. LerouxALAurélia A. Leroux
Open Access
- 26 August 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (17) , 9236
Abstract
Sepsis in the young population, which is particularly at risk, is rarely studied. O-GlcNAcylation is a post-translational modification involved in cell survival, stress response and metabolic regulation. O-GlcNAc stimulation is beneficial in adult septic rats. This modification is physiologically higher in the young rat, potentially limiting the therapeutic potential of O-GlcNAc stimulation in young septic rats. The aim is to evaluate whether O-GlcNAc stimulation can improve sepsis outcome in young rats. Endotoxemic challenge was induced in 28-day-old rats by lipopolysaccharide injection (E. Coli O111:B4, 20 mg·kg−1) and compared to control rats (NaCl 0.9%). One hour after lipopolysaccharide injection, rats were randomly assigned to no therapy, fluidotherapy (NaCl 0.9%, 10 mL·kg−1) ± NButGT (10 mg·kg−1) to increase O-GlcNAcylation levels. Physiological parameters and plasmatic markers were evaluated 2h later. Finally, untargeted mass spectrometry was performed to map cardiac O-GlcNAcylated proteins. Lipopolysaccharide injection induced shock with a decrease in mean arterial pressure and alteration of biological parameters (p < 0.05). NButGT, contrary to fluidotherapy, was associated with an improvement of arterial pressure (p < 0.05). ATP citrate lyase was identified among the O-GlcNAcylated proteins. In conclusion, O-GlcNAc stimulation improves outcomes in young septic rats. Interestingly, identified O-GlcNAcylated proteins are mainly involved in cellular metabolism.Keywords
Funding Information
- Agence Nationale de la Recherche (20‐ASTC‐0032‐01‐hErOiSmE)
- Fonds National de la Recherche Scientifique et Médicale (FNRS, PDR T.0211.18)
- Action de Recherche Concertée de la Communauté Wallonie-Bruxelles (ARC16/21-074)
- Fundamental Research of excellence in Strategic areas – Walloon Excellence in Life Sciences and Biotechnology (FRFS-WELBIO, WELBIO-CR-2019A-01)
This publication has 49 references indexed in Scilit:
- Trends in the Epidemiology of Pediatric Severe Sepsis*Pediatric Critical Care Medicine, 2013
- Increased Beta2-Adrenoceptors in Doxorubicin-Induced Cardiomyopathy in RatPLOS ONE, 2013
- MISC-1/OGC Links Mitochondrial Metabolism, Apoptosis and Insulin SecretionPLOS ONE, 2011
- The Mitochondrial 2-Oxoglutarate Carrier Is Part of a Metabolic Pathway That Mediates Glucose- and Glutamine-stimulated Insulin SecretionJournal of Biological Chemistry, 2010
- Cardiac dysfunction in severe sepsis and septic shockCurrent Opinion in Critical Care, 2009
- Cardioprotection by N -Acetylglucosamine Linkage to Cellular ProteinsCirculation, 2008
- Functional and Structural Role of Amino Acid Residues in the Odd-numbered Transmembrane α-Helices of the Bovine Mitochondrial Oxoglutarate CarrierJournal of Molecular Biology, 2007
- Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein-associated O-GlcNAcAmerican Journal of Physiology-Cell Physiology, 2007
- Insights into Severe Sepsis in Older Patients: From Epidemiology to Evidence-Based ManagementClinical Infectious Diseases, 2005
- Immunological characterization of the mitochondrial 2‐oxoglutarate carrier from liver and heartFEBS Letters, 1990